Physician's Weekly1d
Lesion Time and High-Risk Features in Keratinocyte Skin Cancer
The following is a summary of “St Andrews Referral Delay in Skin Cancer (StARDISC): A study of keratinocyte skin cancer time ...
Nasdaq12d
Medicus Pharma Ltd. Reports Positive Interim Results for Phase 2 Study on Non-Invasive Treatment of Basal Cell Carcinoma
The complete response is defined as the disappearance of BCC histologically in the final ... on histological examination of the resected lesion. The Company submitted a Phase 2 IND clinical ...
Nasdaq1mon
Medicus Pharma Ltd. Reports Progress in Phase 2 Clinical Study of D-MNA for Basal Cell Carcinoma
The complete response is defined as the disappearance of BCC histologically in the final ... on histological examination of the resected lesion. The Company submitted a Phase 2 IND clinical ...